SiSaf is an RNA delivery and therapeutics company. Its proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon.The company’s Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improvethe stability, safety, and transfection efficiency of RNA. SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and is maximizing the potential of its technology through research partnerships.Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, it has fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.

Pharmaceutical

Health Care

Biotechnology

SiSaf Ltd

Dr Suzanne Saffie-Siebert

Tim Brundle

Richard Scarrott

Nissim Torabi-Pour

John Stanton

Joanne Manson

Flavia M. Sutera

Charles Weatherstone

Andy Gibson

Leadership Team

Operations Team

Research and Development

SiSaf Ltd

Org chart

Teams

Leadership Team

Operations Team

Research and Development

Similar companies